MAYO CLINIC ROCHESTER
Reversing abnormal metabolism in mild autonomous cortisol secretion (MACS)
Reversing abnormal metabolism in mild autonomous cortisol secretion (MACS) is a funding opportunity from MAYO CLINIC ROCHESTER, up to 741387, closing December 31, 2030.
Dec 31, 2030
(1614d left)Overview
PROJECT SUMMARY Mild autonomous cortisol secretion (MACS) is diagnosed in up to 44% of patients with adrenal adenomas, affecting 1-2% of the adult population. MACS is diagnosed based on an abnormal cortisol level following dexamethasone suppression (1.8 mcg/dL). Patients with MACS develop high rates of cardiovascular…